Gilead Sciences (GILD) Revenue and Net Income History
Historical revenue, operating income and net income for Gilead Sciences (GILD) over the last 10 years. The current TTM revenue for Gilead Sciences as of September 22, 2017 is $30.39B.
|Medical||Medical - Biomedical and Genetics||$108.744B||$30.390B|
|Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective.|